160 related articles for article (PubMed ID: 35238666)
1. Endovascular embolization for the treatment of epistaxis: Systematic review and meta-analysis.
Hoffman H; Ashok Kumar A; Raventhiranathan N; Masoud HE; Gould GC
Interv Neuroradiol; 2023 Apr; 29(2):172-182. PubMed ID: 35238666
[TBL] [Abstract][Full Text] [Related]
2. Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization.
Trojanowski P; Jargiello T; Trojanowska A; Klatka J
Acta Radiol; 2011 Oct; 52(8):846-9. PubMed ID: 21816895
[TBL] [Abstract][Full Text] [Related]
3. Endovascular treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia.
Layton KF; Kallmes DF; Gray LA; Cloft HJ
AJNR Am J Neuroradiol; 2007 May; 28(5):885-8. PubMed ID: 17494663
[TBL] [Abstract][Full Text] [Related]
4. Endovascular treatment of epistaxis: indications, management, and outcome.
Strach K; Schröck A; Wilhelm K; Greschus S; Tschampa H; Möhlenbruch M; Naehle CP; Jakob M; Gerstner AO; Bootz F; Schild HH; Urbach H
Cardiovasc Intervent Radiol; 2011 Dec; 34(6):1190-8. PubMed ID: 21472510
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis.
Braak SJ; de Witt CA; Disch FJ; Overtoom TT; Westermann JJ
Rhinology; 2009 Jun; 47(2):166-71. PubMed ID: 19593974
[TBL] [Abstract][Full Text] [Related]
6. Selective embolization in the treatment of intractable epistaxis.
Andersen PJ; Kjeldsen AD; Nepper-Rasmussen J
Acta Otolaryngol; 2005 Mar; 125(3):293-7. PubMed ID: 15966700
[TBL] [Abstract][Full Text] [Related]
7. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
Hanks JE; Hunter D; Goding GS; Boyer HC
Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
[TBL] [Abstract][Full Text] [Related]
8. Complications and Outcomes of Endovascular Embolization for Intractable Epistaxis: A Systematic Review and Meta-analysis.
Bonnici M; Orabi NA; Gannon M; Williams N; Stokes CM; Ramadan HH; Turner MT; Makary CA
Ann Otol Rhinol Laryngol; 2023 Oct; 132(10):1233-1248. PubMed ID: 36582148
[TBL] [Abstract][Full Text] [Related]
9. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
[TBL] [Abstract][Full Text] [Related]
10. Cauterization for epistaxis in hereditary hemorrhagic telangiectasia.
Dabiri J; Fakhoury R; Choufani G; Mine B; Hassid S
B-ENT; 2016; 12(1):9-16. PubMed ID: 27097388
[TBL] [Abstract][Full Text] [Related]
11. Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Thiele B; Abdel-Aty Y; Marks L; Lal D; Marino M
Ann Otol Rhinol Laryngol; 2023 Jan; 132(1):82-90. PubMed ID: 35152768
[TBL] [Abstract][Full Text] [Related]
12. Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management.
Sautter NB; Smith TL
Int Forum Allergy Rhinol; 2012; 2(5):422-31. PubMed ID: 22566463
[TBL] [Abstract][Full Text] [Related]
13. Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis.
Hsu YP; Hsu CW; Bai CH; Cheng SW; Chen C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):22-35. PubMed ID: 30200816
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
[TBL] [Abstract][Full Text] [Related]
15. Endovascular Embolization for Epistaxis: A Single Center Experience and Meta-Analysis.
El Naamani K; Morse C; Ghanem M; Barbera J; Amllay A; Severance G; Ruiz R; Sweid A; Gooch MR; Herial NA; Jabbour P; Rosenwasser RH; Nyquist GG; Tjoumakaris S
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002574
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy assessment of current treatment options for epistaxis in HHT.
Dür C; Anschuetz L; Negoias S; Bulut OC; Angelillo-Scherrer A; Caversaccio M
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4321-4328. PubMed ID: 33661356
[TBL] [Abstract][Full Text] [Related]
17. Endovascular Embolization in the Treatment of Epistaxis.
Huyett P; Jankowitz BT; Wang EW; Snyderman CH
Otolaryngol Head Neck Surg; 2019 May; 160(5):822-828. PubMed ID: 30744478
[TBL] [Abstract][Full Text] [Related]
18. ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
Dupuis-Girod S; Ambrun A; Decullier E; Samson G; Roux A; Fargeton AE; Rioufol C; Schwiertz V; Disant F; Chapuis F; Donazzolo Y; Paintaud G; Edery P; Faure F
MAbs; 2014; 6(3):794-9. PubMed ID: 24481211
[TBL] [Abstract][Full Text] [Related]
19. Health-Related Quality of Life Outcome Measures in Individuals With Hereditary Hemorrhagic Telangiectasia: A Scoping Review.
Gong AJ; Garg T; Khalil A; Gowda PC; Mathai SC; Rowan NR; Merlo CA; Weiss CR
Am J Rhinol Allergy; 2024 Jan; 38(1):60-76. PubMed ID: 37855028
[TBL] [Abstract][Full Text] [Related]
20. Arterial ligation versus embolization in epistaxis management: Counterintuitive national trends.
Sylvester MJ; Chung SY; Guinand LA; Govindan A; Baredes S; Eloy JA
Laryngoscope; 2017 May; 127(5):1017-1020. PubMed ID: 28008625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
